| Primary |
| Vertigo |
26.7% |
| Product Used For Unknown Indication |
10.5% |
| Meniere's Disease |
9.3% |
| Emphysema |
7.0% |
| Convulsion |
5.8% |
| Drug Use For Unknown Indication |
5.8% |
| Anticoagulant Therapy |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Alcoholism |
2.3% |
| Balance Disorder |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Depression |
2.3% |
| Dizziness |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hypertension |
2.3% |
| Inner Ear Disorder |
2.3% |
| Pollakiuria |
2.3% |
| Vertigo Positional |
2.3% |
| Antiemetic Supportive Care |
1.2% |
| Arthralgia |
1.2% |
|
| Drug Ineffective |
58.3% |
| Dizziness |
7.0% |
| Hypersensitivity |
4.3% |
| Drug Effect Decreased |
3.5% |
| Drug Exposure During Pregnancy |
2.6% |
| Malaise |
2.6% |
| Vertigo |
2.6% |
| Blood Glucose Decreased |
1.7% |
| Completed Suicide |
1.7% |
| Drug Hypersensitivity |
1.7% |
| Drug Intolerance |
1.7% |
| Dry Mouth |
1.7% |
| Headache |
1.7% |
| Nausea |
1.7% |
| Rash |
1.7% |
| Vision Blurred |
1.7% |
| Abdominal Discomfort |
0.9% |
| Aerophagia |
0.9% |
| Asthenia |
0.9% |
| Blood Potassium Increased |
0.9% |
|
| Secondary |
| Emphysema |
16.8% |
| Convulsion |
12.1% |
| Anticoagulant Therapy |
11.2% |
| Gastrooesophageal Reflux Disease |
6.5% |
| Vertigo |
6.5% |
| Alcoholism |
5.6% |
| Balance Disorder |
5.6% |
| Pollakiuria |
5.6% |
| Dizziness |
4.7% |
| Product Used For Unknown Indication |
4.7% |
| Atrial Fibrillation |
2.8% |
| Hypertension |
2.8% |
| Anxiety |
1.9% |
| Blood Cholesterol Increased |
1.9% |
| Depression |
1.9% |
| Fibromyalgia |
1.9% |
| Meniere's Disease |
1.9% |
| Neuropathy Peripheral |
1.9% |
| Pain |
1.9% |
| Reynold's Syndrome |
1.9% |
|
| Drug Ineffective |
38.5% |
| Completed Suicide |
7.7% |
| Dizziness |
7.7% |
| Weight Decreased |
7.7% |
| Cardiac Arrest |
3.8% |
| Cardiac Disorder |
3.8% |
| Cardio-respiratory Arrest |
3.8% |
| Death |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Hallucination |
3.8% |
| Headache |
3.8% |
| Hunger |
3.8% |
| Hypersensitivity |
3.8% |
| Meniere's Disease |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.7% |
| Drug Use For Unknown Indication |
15.3% |
| Multiple Sclerosis |
6.9% |
| Hypertension |
6.0% |
| Pain |
4.7% |
| Asthma |
4.4% |
| Dizziness |
3.5% |
| Depression |
3.4% |
| Gastrooesophageal Reflux Disease |
3.4% |
| Anxiety |
2.3% |
| Rheumatoid Arthritis |
2.1% |
| Diabetes Mellitus |
1.9% |
| Back Pain |
1.6% |
| Cardiac Failure Congestive |
1.6% |
| Non-small Cell Lung Cancer |
1.6% |
| Dyspnoea |
1.5% |
| Osteoporosis |
1.5% |
| Multiple Myeloma |
1.3% |
| Prophylaxis |
1.3% |
| Blood Cholesterol Increased |
1.1% |
|
| Pain In Extremity |
8.2% |
| Therapeutic Response Decreased |
8.2% |
| Tremor |
8.2% |
| Type 2 Diabetes Mellitus |
8.2% |
| Aneurysm |
6.6% |
| Death |
4.9% |
| Diarrhoea |
4.9% |
| Osteoarthritis |
4.9% |
| Pruritus |
4.9% |
| Thrombocytopenia |
4.9% |
| Vomiting |
4.9% |
| Weight Decreased |
4.9% |
| Anxiety |
3.3% |
| Carotid Artery Occlusion |
3.3% |
| Chest Pain |
3.3% |
| Disturbance In Attention |
3.3% |
| Flushing |
3.3% |
| Headache |
3.3% |
| Hypoxia |
3.3% |
| Injury |
3.3% |
|
| Interacting |
| Hypertension |
21.4% |
| Anticoagulant Therapy |
14.3% |
| Dementia |
14.3% |
| Dizziness |
14.3% |
| Pain |
14.3% |
| Blood Cholesterol Abnormal |
7.1% |
| Blood Cholesterol Increased |
7.1% |
| Vertigo |
7.1% |
|
| Hallucination |
66.7% |
| Drug Interaction |
33.3% |
|
